Education
About Us
Working with TipRanks
Follow Us
Jason Lettmann Insider Profile
4 Followers
Jason Lettmann, CEO, Director at ALX Oncology Holdings, holds 170.27K shares in ALX Oncology Holdings (Ticker: ALXO).
Jason Lettmann ALX Oncology Holdings (ALXO)CEO, Director
ALX Oncology Holdings (ALXO)
CEO, Director
Ranked #16,064 out of 100,956 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+30.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Jason Lettmann holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 21, 2020 - Jul 21, 2021
Return:+89.70%
The most profitable trade made by Jason Lettmann
Jason Lettmann's Trading History
List of latest transactions for each holding click on a transaction to see Jason Lettmann's performance on stock
You May Also Like
Jason Lettmann insider profile FAQ
What is the percentage of profitable transactions made by Jason Lettmann?
The percentage of profitable transactions made by Jason Lettmann is 75%.
What is the average return per transaction made by Jason Lettmann?
The average return per transaction made by Jason Lettmann is 30.50%.
What stocks does Jason Lettmann hold?
Jason Lettmann holds: ALXO stocks.
What was Jason Lettmann’s latest transaction?
Jason Lettmann latest transaction was an Uninformative Sell of $2.48K.
What was Jason Lettmann's most profitable transaction?
Jason Lettmann’s most profitable transaction was an Informative Buy of ALXO stock on July 21, 2020. The return on the trade was 89.70%.
What is Jason Lettmann's role in ALX Oncology Holdings?
Jason Lettmann's role in ALX Oncology Holdings is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.